Patents - Global Data - Dimensions
DISRUPTION OF ASXL1 IN T CELLS TO ENHANCE IMMUNOTHERAPY
Inventors:
Youngblood, Benjamin Alan
0000-0002-1261-9957
Zebley, Caitlin C
0000-0002-8419-4660
Grønbæk, Kirsten
0000-0002-1535-9601
Applicants:
- Rigshospitalet [NORA names: Capital Region of Denmark; Hospital; Denmark; Europe, EU; Nordic; OECD]
- St. Jude Children's Research Hospital [NORA names: United States; America, North; OECD]
Abstract
The application relates to modified immune effector cells with enhanced immune cell function, as well as related pharmaceutical compositions. The application further relates to methods for generating the modified immune effector cell and methods for using the modified immune effector cell for treatment of diseases (e.g., adoptive cell therapy).
Patent Family Records (1)
DISRUPTION OF ASXL1 IN T CELLS TO ENHANCE IMMUNOTHERAPY
RIGSHOSPITALET, Rigshospitalet, ST JUDE CHILDRENS RES HOSPITAL INC, St. Jude Children's Research Hospital Youngblood, Benjamin Alan, Zebley, Caitlin C, Kang, Tae Gun, (...more)
2024, WO-2024059787-A1
